MAL2

Chr 8

mal, T cell differentiation protein 2

The protein is a transmembrane component of lipid rafts that is required for transcytosis, the intracellular transport pathway that delivers proteins and cargo from the basolateral to apical cell surface in polarized cells. Mutations cause autosomal recessive congenital diarrhea with protein-losing enteropathy, presenting in early infancy with severe diarrhea and failure to thrive due to intestinal epithelial transport defects. This gene shows relatively low constraint to loss-of-function variants.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
7
Pubs (1 yr)
55
P/LP submissions
0%
P/LP missense
1.10
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMAL2
Population Constraint (gnomAD)
Low constraint (pLI 0.14) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
55 unique Pathogenic / Likely Pathogenic· 17 VUS of 85 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.10LOEUF
pLI 0.137
Z-score 1.43
OE 0.35 (0.141.10)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.50Z-score
OE missense 0.84 (0.691.03)
67 obs / 79.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.35 (0.141.10)
00.351.4
Missense OE0.84 (0.691.03)
00.61.4
Synonymous OE0.98
01.21.6
LoF obs/exp: 2 / 5.7Missense obs/exp: 67 / 79.4Syn Z: 0.09
DN
0.79top 25%
GOF
0.85top 5%
LOF
0.1993th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

85 submitted variants in ClinVar

Classification Summary

Pathogenic55
VUS17
Likely Benign2
55
Pathogenic
17
VUS
2
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
55
0
55
Likely Pathogenic
0
0
0
0
0
VUS
0
11
6
0
17
Likely Benign
0
0
2
0
2
Benign
0
0
0
0
0
Total01163074

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MAL2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →